Skip to main content

Sensex down by over 400 points; Nifty holds 11,200

Sectorally, the S&P BSE Healthcare index rose 2.1 percent, S&P BSE Metal index was up 0.98 percent and the telecom index closed with gains of 0.69 percent.

 

The bears took control of D-Street on July 29, pushing benchmark indices towards the crucial support levels. The S&P BSE Sensex fell more than 400 points but managed to hold on to the 38,000 level while the Nifty held on to 11,200 level.

The S&P BSE Sensex fell 421 points to end the day at 38,071 while the Nifty50 ended 97 points lower at 11,202.

Profit booking after the recent rally, US Fed meeting, a rise in coronavirus cases and mixed earnings capped the upside, experts say.



"Indian indices gave up gains and closed in the negative with profit-booking seen in the recent outperformer RIL,” Vinod Nair, Head of Research at Geojit Financial told Moneycontrol.

Global markets were undecided ahead of the US Fed Reserve meeting. Mixed earnings reports and rising virus cases forcing economies to reconsider restrictions also weighed on sentiment.

“Stock-specific action was also visible, post-earnings results and this trend is expected to continue. Adequate liquidity in the market should ensure that these corrections are bought into,” Nair said.

Sectorally, action was seen in healthcare, metal, telecom, and capital goods while selling pressure was visible in energy, auto, and oil & gas space.

The broader markets outperformed the benchmarks. The S&P BSE Midcap index rose 0.68 percent while the S&P BSE Smallcap index closed with gains of 0.43 percent .

Top Nifty gainers included Tata Steel, IndusInd Bank and Dr Reddy’s Laboratories.

Top Nifty losers included M&M, HCL Technologies, Nestle India and RIL.

Stocks & Sectors

Sectorally, the S&P BSE Healthcare index rose 2.1 percent followed by the S&P BSE Metal index that was up 0.98 percent and the S&P BSE Telecom index closed 0.69 percent higher.

Selling pressure was seen in the energy index that fell 3 percent followed by the auto index that was down 1.2 percent and the BSE oil & gas index closed with a loss of 1.08 percent.

A volume spike of more than 100 percent was seen in REC, Colgate Palmolive, and RBL Bank.

Long buildup was seen in stocks like Colgate Palmolive, PFC and BHEL.

Short buildup was seen in stocks like BPCL, TCS and Maruti Suzuki.

More than 100 stocks on the BSE hit a fresh 52-week high. These included Dr Reddy’s Laboratories, TCS, MCX India, MindTree and Jubilant Life Sciences.

Stocks in news

Dr Reddy's Laboratories stock jumped over 6 percent after the company reported a 12.6 percent year-on-year (YoY) drop in consolidated net profit at Rs 579 crore for the quarter ended June 2020.

Maruti Suzuki India share price shed over a percent after the company posted a net loss of Rs 249.4 crore for the June quarter.

IDBI Bank stock price jumped 5 percent after the lender reported a standalone net profit of Rs 144.43 crore for the June quarter.

Jet Airways shares shed 5 percent after the company posted a weak set of numbers for the financial year 2019.

Sasken Technologies stock surged 14 percent after the company posted 200 percent QoQ jump in Q1 net profit at Rs 28.3 crore against Rs 9.4 crore.

Tata Coffee share price jumped over 12 percent after the company declared its June quarter numbers.

Technical View

The Nifty formed a bearish candle on the daily chart. It bounced back from 5-Days EMA placed at 11,189

The Nifty surpassed the previous day’s high of 11,317 but in the absence of buying, took the index to retest the low of 11,150.

The Nifty is stuck in a range between 11050 and 11350 and requires a decisive breakout with follow-up action to commence the next leg of rally, Chandan Taparia of Motilal Oswal Financial Services Limited said.

“Now, it has to continue to hold 11,150 zone to extend its move towards 11,350 then 11,500 zones while on the downside, key support exists at 11,050 levels,” he said.



Sourse - Moneycontrol.com


Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Indigo Paints trades at over 55% premium in grey market after IPO price announcement

The grey market premium has increased significantly from Rs 400-500 on January 11 to Rs 840-850 on January 15. Indigo Paints, one of the fastest-growing paint companies in India, was trading at more than 50 percent premium over its higher issue price band of Rs 1,490 per share in the grey market after the announcement of IPO details. The premium in the grey market as of January 15 was at around Rs 840-850 per share, which means the grey market trading price stood at Rs 2,340-2,330 against the issue price of Rs 1,490, as per the data available on IPO Watch. The premium increased significantly from Rs 400-500 on January 11 to Rs 840-850 today. The grey market is an unofficial trading platform where shares get traded well before the allotment in an initial public offering and till the shares get listed on bourses. It generally estimates the expected listing price of a stock. "Currently Asian paints and Berger paints are trading at a PE of 111 and 148, respectively, while Indigo Paint...
Post a Comment
Read more